We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Teva Pharmaceutical Indus 30-Day Option Volume & Interest Snapshot Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its ...

Teva and NICE Systems lost ground as the banks rose. The Tel Aviv Stock Exchange fell today. The Tel Aviv 35 Index fell 0.67%, to 2,491.34 points, the Tel Aviv 125 Index fell 0.37% to 2,564.04 points; ...

Please find enclosed the Scrutinizer''s Report on the business transacted at the Extraordinary General Meeting of the Company held on Tuesday, 4th February 2025.

Teva Pharmaceutical (NYSE:TEVA) shares snapped six straight sessions of losses, as the stock closed 0.88% higher at $17.21 on Wednesday. The company lost over 20% in the preceding six sessions.

Drug major Sun Pharmaceutical Industries Ltd on Tuesday (February 4) said it has been penalised ₹160.2 crore by the Additional Commissioner of Central GST & Central Excise, Surat, under Section 74(1) ...

Teva Pharma Industries Ltd ADR (NYSE:TEVA) is the world's largest generic drug maker, with over 500 generic and biosimilar treatments in its broad portfolio. The medical sector giant also has a ...

TEL AVIV (Reuters) - Israel-based Teva Pharmaceutical Industries (TA:TEVA) will name AstraZeneca (L:AZN) chief executive Pascal Soriot as its next CEO, the Calcalist financial... Investing.com ...

Shares of NYSE TEVA opened at $17.81 on Thursday. Teva Pharmaceutical Industries has a 12 month low of $11.62 and a 12 month high of $22.80. The company has a market cap of $20.17 billion, a P/E ...

A brief financial summary of Sudarshan Pharma Industries Ltd as well as the most significant critical numbers from each of its financial reports. In addition, some financial ratios derived from these ...

2025 Free Cash Flow Guidance: $1.6 billion to $1.9 billion. Teva Pharmaceutical Industries Ltd (NYSE:TEVA) reported a 9% increase in revenue for 2024, reaching $16.5 billion, driven by strong ...